Literature DB >> 19515508

Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb--a review of 60 cases.

Michael Poulsen1, Caroline Round, Jacqui Keller, Lee Tripcony, Michael Veness.   

Abstract

PURPOSE: Factors affecting relapse-free survival (RFS) in patients with Merkel cell carcinoma (MCC) of the lower limb were reviewed. METHODS AND MATERIALS: The records of 60 patients from 1986 to 2005 with a diagnosis of MCC of the lower limb or buttock were retrospectively reviewed. The patients were treated with curative intent with surgery, radiation, or chemotherapy.
RESULTS: The 5-year overall survival, disease-specific survival, and RFS were 53%, 61%, and 20%, respectively. Factors influencing RFS were analyzed using univariate analysis. It appeared that recurrent disease worsened RFS (p = 0.03) and the addition of any radiotherapy improved RFS (p <0.001), as did radiotherapy to the inguinal nodes (p = 0.01) or primary site and inguinal nodes (p = 0.003). Age, surgical margins, and stage were not statistically significant. On multivariate analysis, the only significant factor was the addition of radiotherapy (hazard ratio = 0.51 p = 0.03).
CONCLUSION: The addition of radiotherapy improves RFS compared with surgery alone. Elective treatment should be given to the inguinal nodes to reduce the risk of relapse. Crown Copyright 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19515508     DOI: 10.1016/j.ijrobp.2009.02.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Merkel cell carcinoma.

Authors:  Emma Ramahi; Jehee Choi; Clifton D Fuller; Tony Y Eng
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

2.  Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.

Authors:  Shayan Cheraghlou; George O Agogo; Michael Girardi
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

3.  Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy.

Authors:  Lilit Garibyan; Shane E Cotter; Jorgen L Hansen; Claire Noell; Andrew Dorosario; Desmond A O'Farrell; Phillip M Devlin; Linda C Wang
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

4.  Radiation therapy in the management of Merkel cell carcinoma: current perspectives.

Authors:  Zoe Rush; Ryan C Fields; Nancy Lee; Isaac Brownell
Journal:  Expert Rev Dermatol       Date:  2011-08

5.  A practical update of surgical management of merkel cell carcinoma of the skin.

Authors:  Patricia Tai
Journal:  ISRN Surg       Date:  2013-01-30

6.  Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh
Journal:  J Natl Compr Canc Netw       Date:  2018-06       Impact factor: 12.693

Review 7.  Risk of second cancers in merkel cell carcinoma: a meta-analysis of population based cohort studies.

Authors:  Anshul Saxena; Muni Rubens; Venkataraghavan Ramamoorthy; Hafiz Khan
Journal:  J Skin Cancer       Date:  2014-12-10

8.  Survival outcomes and epidemiology of Merkel cell carcinoma of the lower limb and hip: A Surveillance, Epidemiology, and End Results analysis 2000-2018.

Authors:  Matteo Scampa; Rastine Merat; Evangelia Tzika; Daniel F Kalbermatten; Carlo M Oranges
Journal:  JAAD Int       Date:  2022-02-23

Review 9.  The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature.

Authors:  Shaakir Hasan; Liyu Liu; Jacob Triplet; Zhen Li; David Mansur
Journal:  Front Oncol       Date:  2013-11-14       Impact factor: 6.244

10.  Volumetric Modulated Arc Therapy Capabilities for Treating Lower-Extremity Skin Affected by Several Merkel Cell Carcinoma Nodules: When Technological Advances Effectively Achieve the Palliative Therapeutic Goal while Minimising the Risk of Potential Toxicities.

Authors:  Gianluca Ferini; Vito Valenti; Ivana Puliafito; Salvatore Ivan Illari; Valentina Anna Marchese; Giuseppina Rita Borzì
Journal:  Medicina (Kaunas)       Date:  2021-12-18       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.